ABSTRACT

This book summarizes the global progress in medical and scientific research toward converting traditionally chronic autoimmune diseases into a drug-free reversible illness using hematopoietic stem cell transplantation (HSCT) and other cellular therapies such as T regulatory cells (Treg), mesenchymal stromal/stem cells, and chimeric antigen receptor T (CAR T) cells in order to reintroduce sustained immune tolerance. This title provides information on different types of stem cells and immune cells; post-transplant immune regeneration; cellular regulatory requirements; ethical and economic considerations; and the advantages and disadvantages of HSCT in the treatment of a variety of autoimmune diseases versus current conventional treatments. Arranged by disease, the text provides a comprehensive guide to HSCT for all types of autoimmune/immune disorders including monogenetic autoimmune diseases; autoimmune aplastic anemia; neurologic immune diseases including multiple sclerosis, chronic inflammatory demyelinating polyneuropathy, neuromyelitis optica, and stiff person syndrome; rheumatologic diseases such as systemic sclerosis and systemic lupus erythematosus; dermatologic diseases such as pemphigus; gastrointestinal disorders such as Crohn’s disease and celiac disease; and immune-mediated endocrinologic disease type I diabetes mellitus. Guidance is provided on the transplantation technique, cell collection and processing, conditioning regimens, infections, and early and late complications.

Key Features

  • Outlines therapies and techniques for HSCT for autoimmune diseases
  • Discusses the advantages of HSCT over conventional therapies
  • Reviews the entire process of stem cell therapy from harvest and ethics to indications, efficacy, and regulatory oversight

part Section III|20 pages

Regulatory Requirements

part Section IV|67 pages

Mesenchymal Stem Cells for Immune Diseases

part Section V|103 pages

General Concepts — HSCT for Autoimmune Diseases

chapter 30|7 pages

Transfusion Medicine

chapter 31|11 pages

International Registries Sites/Indications/Activity for Hsct in Autoimmune Diseases

The European Society for Blood and Marrow Transplantation (EBMT) and Center for International Blood and Marrow Transplant Research (CIBMTR)

part Section VI|43 pages

Allogeneic HSCT for Autoimmune Disease

part Section VII|191 pages

HSCT for Autoimmune Disease

chapter 43|8 pages

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Basics and Interpretation of Electrodiagnostic Testing

chapter 46|10 pages

Neuromyelitis Optica

Autologous and Allogeneic HSCT for AQP4-IgG-Positive Neuromyelitis Optica Spectrum Disorders

chapter 48|14 pages

The Systemic Sclerosis Heart

chapter 52|9 pages

Crohn's Disease

Incidence, Diagnosis, Standard Treatment, Prognosis, Outcome Measures

chapter 54|9 pages

Type 1 Diabetes Mellitus

Hematopoietic Stem Cell Transplantation for Type 1 Diabetes Mellitus

chapter 55|8 pages

Systemic Lupus Erythematosus

Hematopoietic Stem Cell Transplantation for Systemic Lupus Erythematosus (SLE)

part Section VIII|73 pages

HSCT for Autoimmune Disease — Developing Indications

chapter 56|8 pages

Refractory Celiac Disease

Hematopoietic Stem Cell Transplantation for Refractory Celiac Disease Type II